← Leaderboards
Jeffrey O Hollinger
Carnegie-Mellon University
$1,945,907
Attributed
$1,945,907
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $309.9K · FY2005–06$500K$375K$250K$125K$0
'05
'06
Funding mix
By agency
NIH$1,945,907 · 2
By mechanism
R01$1,945,907 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Tissue Engineering”
- Wesley Ian Sundquist · Utah State Higher Education System--University Of Utah$47,918,780
- Robert Stanley Sherwin · Yale University$43,700,325
- Gordana Vunjak-Novakovic · Tufts University Medford$36,226,687
- Louis J. Picker · Oregon Health And Science University$34,577,072
- Karl Alexander Deisseroth · Stanford University$34,039,874
- David S Perlin · Hackensack University Medical Center$33,316,814
Research focus
Tissue EngineeringBone RegenerationOsteoblastsLaboratory RatDogsTransfection /Expression VectorAnimal Old AgeBiomaterial Development /PreparationBiomaterial EvaluationBone Morphogenetic ProteinsDrug Delivery SystemsMacaca MulattaOral Facial RestorationOral Facial Restoration MaterialPolymersRecombinant ProteinsTechnology /Technique DevelopmentTissue /Cell CultureTransfectionAge DifferenceCell DifferentiationPeriodontium DisorderDental Disorder ChemotherapyDental Alveolus
Grant awards (7)
Alveolar Bone Regeneration by Transcriptional Control$304,614
R01 · FY2006 · DE · contact PI
Alveolar Bone Regeneration by Transcriptional Control$309,914
R01 · FY2005 · DE
Alveolar Bone Regeneration by Transcriptional Control$232,482
R01 · FY2004 · DE
Alveolar Bone Regeneration by Transcriptional Control$296,224
R01 · FY2003 · DE
ENGINEERING AN OROFACIAL BONE REGENERATIVE THERAPY$262,616
R01 · FY2002 · DE
ENGINEERING AN OROFACIAL BONE REGENERATIVE THERAPY$263,580
R01 · FY2001 · DE
ENGINEERING AN OROFACIAL BONE REGENERATIVE THERAPY$276,477
R01 · FY2000 · DE